Andrew Garvie 46th Lorne Genome Conference 2025

Abstracts this author is presenting:

• RNA Polymerase I inhibition as a therapeutic strategy for treating H3.3 and ATRX mutated gliomas. — Concurrent Session 5B - Genome in Disease